Skip to content

EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest

EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest With no Obvious Non Cardiac Cause of Arrest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02876458
Acronym
EMERGE
Enrollment
336
Registered
2016-08-23
Start date
2017-01-31
Completion date
2020-11-23
Last updated
2021-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out-of-Hospital Cardiac Arrest

Keywords

Coronary angiogram, Survival rate, Neurological sequel

Brief summary

Sudden cardiac death (SCD) remains a major public health issue with a low survival rate. The most common cause of SCD is acute coronary artery occlusion. Several registry based studies suggest that coronary angiography (CA) performed at admission followed if necessary by coronary angioplasty improves in-hospital and long term survival. Recent guidelines recommend performing an immediate CA in all survivors of SCD with no obvious non cardiac cause of arrest. However there is a lack of randomized data on this topic. Several retrospective studies have shown that if the post-resuscitation electrocardiogram (ECG) shows ST segment elevation, the probability of finding an acute coronary artery lesion during the CA is high (70-80%). In contrast, if no ST segment elevation is present the probability is low (15-20%). Performing an immediate CA in all survivors of SCD can be challenging. It requires admitting these patients to centers with an intensive care unit and facilities allowing 24/24 7/7 CA. It may increase the delay of performing other therapeutic modalities such as CT brain or thorax scan to determine the cause of SCD. Performing the CA 48 to 96 hours after admission would facilitate the management of these difficult patients. However if the cause of the arrest is a coronary artery occlusion and there is a delay in reperfusion, the rate of post-arrest shock and the mortality may increase. Therefore a randomized study comparing immediate versus delayed (between 48 to 96 hours) CA in survivors of SCD with no obvious non-cardiac cause of arrest is warranted.

Detailed description

The design consists in a multicenter national randomized open parallel group trial. All eligible patients with SCD will be included and randomized by the Emergency Medical Service (EMS) to one of the 2 following arms: immediate CA vs delayed CA. Patients randomized in the immediate CA group will be admitted directly to the catheterization laboratory. Patients randomized in the delayed CA will be admitted to the intensive care unit and a CA will be planned 48 to 96 hours after admission. Investigators can perform the CA in the delayed group \< 48 hours if the following events appear: * ST segment elevation or new left bundle branch block on the ECG * Shock unresponsive to inotropes * Electrical storm (repeated Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF)) * Segmental hypokinesia or akinesia on an echocardiogram Echocardiography and assessment of neurological status are done at discharge form the Intensive Care Unit, at hospital discharge and during the follow-up visits (90 and 180 days).

Interventions

OTHERImmediate coronary angiogram

An immediate coronary angiogram will be performed

OTHERDelayed coronary angiogram

A delayed coronary angiogram (between 48 to 96 hours) will be performed

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Out-of-hospital SCD with return of spontaneous circulation * Age ≥ 18 years of age * No obvious non-cardiac cause of arrest * Admitted to a center with an intensive care unit and a 24 hours a day, 7 days a week interventional cardiology department * Affiliation to the French Social Security Health Care plan

Exclusion criteria

* Age \< 18 years of age * In-hospital SCD * No return of spontaneous circulation * Presence of ST segment elevation * Suspected non-cardiac aetiology (trauma, respiratory, neurological, etc.) * Presence of co-morbidities with life expectancy of less than a year * Pregnancy * Adults subject to a legal protection measure (guardianship or tutelage measure) * Participation in another interventional trial

Design outcomes

Primary

MeasureTime frameDescription
Survival with no or minimal neurological sequel180 daysSurvival rate with no or minimal neurological sequel (CPC (cerebral performance category) 1 or 2) at 6 months after inclusion

Secondary

MeasureTime frameDescription
Arrhythmia48 hoursThe rate of VT/VF during the first 48 hours between immediate and delayed CA
The evolution of left ventricular ejection fraction evolution180 daysChanges in left ventricular ejection fraction between baseline and 180 days assessed by echocardiogram between immediate and delayed CA
CPC score180 daysThe rate of neurological sequel assessed by the CPC score between immediate and delayed CA
Shock48 hoursThe rate of shock during the first 48 hours between immediate and delayed CA
Overall survival rate180 daysThe overall survival rate between immediate and delayed CA
Hospital stay length180 daysThe length of hospital stay between immediate and delayed CA
Glasgow Outcome Scale Extended score (GOSE)180 daysThe rate of neurological sequel assessed by the GOSE between immediate and delayed CA

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026